MABSOLVE LIMITED
Company number 12347440 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£896,737
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-12-04
- Employees
- 3 (2025 accounts)
- Registered office
- The Wheelhouse Angel Court First Floor, Angel Court, 81 St Clements Street, Oxford, England, OX4 1AW
- Postcode
- OX4 1AW
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-12-03
- Next due by
- 2026-12-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current
Data protection registration
Registered with the ICO as a data protection fee payer — ZA818108 (Tier 1), registered since 2020.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- mabsolve.co.uk
Building on 40 years of innovation Our Technology Building on 40 years of innovation we have developed a novel Fc variant which is comprehensively more silenced than all previous attempts (including LALA, LALAPG, aglycosylated etc). For approximately 50% of antibody and Fc fusion proteins in clinical development, Fc effector function is not a mechanism of
Previous registered addresses 1
| Address | Changed on |
|---|---|
| WILTON CENTRE C/O ABSOLUTE ANTIBODY LIMITED, WILTON, REDCAR, CLEVELAND, TS10 4RF, UNITED KINGDOM | 2020-11-23 |
Among its peers
Top 25%
by shareholders' funds, of 179 similar companies in OX
Trading since 2019.
Competitors Oxford
This company ranks 42 among research and experimental development on biotechnology in Oxford.
The class of 2019
39%
of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.
A fact about the year, not a forecast for this company.